The most interesting thing we hear from SugarShield customers is not simply that they crave less sugar. It is that cravings often become quieter while energy becomes steadier.

That pairing matters.

Most weight-loss advice assumes the opposite tradeoff: eat less, tolerate more hunger, and expect energy to dip while the body adjusts. But when the desire for food and the feeling of low energy ease together, it suggests both may have been driven by the same metabolic signal.

This is what LIV3's Fructose Model predicts.

The model proposes that fructose is not merely another source of calories. Through a distinct metabolic pathway, it can help tell the body to conserve fuel, store energy, and keep looking for more. In the right setting, that is elegant survival biology. When the pathway is activated too often, the same program may feel like persistent cravings, unreliable energy, and a body that stores fuel more readily than it uses it.

SugarShield was designed around that idea. Its central ingredient, luteolin, has been shown to inhibit fructokinase—the enzyme at the entrance to fructose metabolism—in biochemical and human kidney-cell experiments. Tart cherry adds a complementary polyphenol strategy around uric acid, oxidative stress, inflammation, and recovery. A liposomal delivery system addresses the practical challenge of getting more from an ingredient that is not absorbed efficiently in conventional form.

So what should someone expect? Not a scripted Day 3 or Day 30 transformation. The better question is whether cravings and energy begin to change as a pair—and what that pattern reveals about the biology underneath.

Why cravings and low energy may belong to the same system

The Fructose Model connects cravings and fatigue through cellular energy. It proposes that fructose metabolism can create a temporary energy drop inside cells while shifting the body toward fuel conservation and storage.

Glucose and fructose contain the same number of calories, but they do not send identical metabolic instructions. Glucose is broadly used as fuel. Fructose is rapidly pulled into a pathway that begins with ketohexokinase, also called fructokinase or KHK.

KHK spends ATP—the cell's immediately usable energy—to convert fructose into fructose-1-phosphate. When fructose arrives quickly enough, phosphate can become temporarily tied up, ATP can fall, and AMP can be broken down toward uric acid.¹

The sequence is straightforward:

Fructose → KHK → ATP consumption → phosphate sequestration → AMP breakdown → uric acid

Richard Johnson and colleagues have proposed that the pathway forms part of an evolutionary survival response: reduce readily available cellular energy, increase hunger and food seeking, conserve fuel, and build reserves for scarcity.^1,2

That helps explain a familiar paradox. A person can have plenty of stored energy and still feel driven to find more. Cells respond not to calories in the abstract, but to whether energy is available in the right form, place, and moment.

If fructose metabolism helps coordinate both the search for fuel and the conservation of fuel, then cravings and low energy should often travel together. If the signal is reduced, the model predicts that they may quiet together as well.

That is why the recurring SugarShield reports matter. Quieter cravings plus steadier energy is precisely the pattern the model would lead us to look for.

Why luteolin sits at the center of SugarShield

Luteolin is important to LIV3 because it has a specific research target: KHK. It is not included merely because it appears on a long list of antioxidants.

In a 2017 Nature Communications study, luteolin inhibited KHK in an enzyme assay and in lysates from human proximal-tubule cells. In mice with ischemic kidney injury, intravenous luteolin also changed fructose handling in the expected direction and reduced markers of injury.³

This is unusually specific evidence for a plant compound: a defined enzyme, direct inhibition, and a biological response consistent with blocking the pathway. The next question is how strongly an oral formulation engages KHK in people—and whether that explains the experiences customers report.

For the deeper evidence, see Is Luteolin a Fructokinase Inhibitor? and LIV3's luteolin research guide.

Why liposomal delivery matters

A promising ingredient still has to reach the body in a useful form. Luteolin is absorbed in humans, but it is also rapidly transformed into metabolites.⁴ Animal studies have found that lipid and phospholipid delivery systems can substantially increase exposure compared with unformulated luteolin.^5,6

Liposomal delivery follows the same practical logic: improve dispersion and create a better opportunity for absorption. SugarShield was built to address a known limitation rather than ignore it. The guide to choosing a liposomal luteolin supplement explains the formulation question in more detail.

What tart cherry adds to the formulation

Tart cherry complements the upstream KHK strategy with polyphenols relevant to the metabolic environment downstream. Its anthocyanins and related compounds have been studied in people for exercise recovery, soreness, inflammation, and uric-acid metabolism.

A meta-analysis of 14 exercise studies found small-to-moderate improvements in soreness and the recovery of strength and power, alongside small changes in some inflammatory markers.⁷ In a randomized crossover trial of 26 adults with overweight or obesity, four weeks of tart-cherry juice reduced serum uric acid compared with the control condition.⁸ These specific preparations were not SugarShield, but they explain why tart cherry belongs in the formulation: it approaches the same metabolic terrain from a complementary direction.

For a broader review, see LIV3's tart cherry evidence guide.

What customers most often notice

Customer reports and reviews repeatedly describe a recognizable cluster rather than one dramatic event:

• food thoughts becoming less persistent;
• sweets feeling easier to pass without a prolonged internal argument;
• fewer afternoon energy swings;
• feeling less dependent on a snack for a temporary lift;
• less sense that managing food requires a constant contest of willpower.

These are recurring qualitative reports, not a formal response rate. Their value is the pattern: if the drive to seek fuel and the tendency to conserve it share a fructose-linked signal, cravings and energy should improve together.

Weight or body composition may change later for some people, particularly if quieter cravings make daily choices easier. But that is not the most revealing first signal. The more immediate question is whether the internal pressure around food changes while usable energy feels more reliable.

Use the three-month trial as an experiment

SugarShield's three-month trial is more useful as a structured personal experiment than as a countdown.

1. Record the starting pattern. For one week, rate cravings and afternoon energy from 1 to 10. Note how often you seek sweets or snack mainly for a lift.
2. Use SugarShield consistently. Changing the routine every few days makes the result hard to interpret.
3. Look for paired movement. Once a week, ask whether food feels less demanding and energy less volatile. The trend matters more than a single unusually good day.
4. Judge the full pattern at three months. Did the relationship with food change? Did energy become more dependable? Did those changes make healthier choices feel less effortful?

A practical test of the Fructose Model

SugarShield is not simply a collection of fashionable antioxidants. It is an attempt to act on a specific metabolic model.

The model begins with a simple distinction: glucose is primarily fuel; fructose can also act as a fuel-conservation signal. KHK sits at the pathway's entrance. Luteolin is a direct experimental KHK inhibitor. Liposomal delivery addresses luteolin's absorption challenge. Tart cherry adds complementary polyphenol support around the downstream environment.

Then comes the test that matters in daily life.

If cravings become quieter while energy becomes steadier, that is personally meaningful validation that the model may be describing something real about your metabolism. It is also the recurring signal that should guide the next generation of formal SugarShield research.

The goal is not to win a battle against willpower. It is to ask whether changing the metabolic signal makes willpower less necessary.

Explore SugarShield and the three-month trial.

References

1. Johnson RJ, Lanaspa MA, Sanchez-Lozada LG, et al. The fructose survival hypothesis for obesity. Philosophical Transactions of the Royal Society B. 2023;378:20220230. doi:10.1098/rstb.2022.0230.
2. Johnson RJ, Sánchez-Lozada LG, Lanaspa MA. The fructose survival hypothesis as a mechanism for unifying the various obesity hypotheses. Obesity. 2024;32:12–22. doi:10.1002/oby.23920.
3. Andres-Hernando A, Li N, Cicerchi C, et al. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice. Nature Communications. 2017;8:14181. doi:10.1038/ncomms14181.
4. Shimoi K, Okada H, Furugori M, et al. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Letters. 1998;438:220–224. doi:10.1016/S0014-5793(98)01304-0.
5. Liu Y, Wang L, Zhao Y, et al. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. International Journal of Pharmaceutics. 2014;476:169–177. doi:10.1016/j.ijpharm.2014.09.052.
6. Khan J, Saraf S, Saraf S. Preparation and evaluation of luteolin-phospholipid complex as an effective drug delivery tool. Pharmaceutical Development and Technology. 2016;21:475–486. doi:10.3109/10837450.2015.1022786.
7. Hill JA, Keane KM, Quinlan R, Howatson G. Tart cherry supplementation and recovery from strenuous exercise: a systematic review and meta-analysis. International Journal of Sport Nutrition and Exercise Metabolism. 2021;31:154–167. doi:10.1123/ijsnem.2020-0145.
8. Martin KR, Coles KM. Consumption of 100% tart cherry juice reduces serum urate in overweight and obese adults. Current Developments in Nutrition. 2019;3:nzz011. doi:10.1093/cdn/nzz011.